Vueway 485.1 mg/mL (Gadopiclenol INJECTION) 485.1 mg/mL

Vueway 485.1 mg/mL is a gadopiclenol injection used for magnetic resonance imaging (MRI) contrast enhancement. This single-dose intravenous solution is designed to improve the visibility of internal structures during diagnostic imaging procedures.

Strength

485.1 mg/mL

Pack Size

10 VIAL, SINGLE-DOSE in 1 CASE (0270-7025-40) / 7.5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

BRACCO DIAGNOSTICS INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Vueway 485.1 mg/mL is primarily used as a contrast agent in MRI scans. It helps to enhance the clarity of images, making it easier for healthcare professionals to detect and diagnose various conditions. The injection is administered intravenously and is commonly used in diagnostic imaging to improve the visibility of blood vessels, organs, and tissues.

Side Effects

Common effects of Vueway 485.1 mg/mL may include temporary discomfort at the injection site, such as redness or swelling. Some individuals might experience a warm sensation or mild nausea. These effects are generally short-lived and resolve quickly. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

Vueway 485.1 mg/mL should be handled with care, ensuring proper sterile techniques are followed during administration. It is important to inform healthcare providers of any known allergies or sensitivities to contrast agents. Patients with kidney issues should discuss potential risks with their healthcare provider before use.

Avoid Interactions

Vueway 485.1 mg/mL may interact with certain medications or medical conditions. It is advisable to disclose all current medications and health conditions to the healthcare provider before administration. Specific interactions with alcohol or other substances have not been widely documented, but general precautions should be taken.

Frequently Asked Questions

Vueway 485.1 mg/mL is used as a contrast agent to enhance the visibility of internal structures during MRI scans.

Vueway 485.1 mg/mL is administered intravenously by a healthcare professional during an MRI procedure.

Common effects may include temporary discomfort at the injection site, such as redness or swelling, and a warm sensation.

Individuals with known allergies to contrast agents or those with kidney issues should consult a healthcare provider before use.

Potential interactions with other medications or health conditions should be discussed with a healthcare provider before administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.